Bird Flu (H5N1 Avian Influenza) Vaccine Clinical Trials
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Safety and Immunogenicity of Inactivated Influenza A/H5N1 Vaccine Administered With or Without Topical Aldara
Conditions: Avian Influenza; Influenza Immunisation Interventions: Other: Aqueous Cream B.P.; Drug: Imiquimod; Biological: Influenza Virus Vaccine, Monovalent A/H5N1 A/Vietnam/1203/04 Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2018 Category: Research Source Type: clinical trials
Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Inactivated Influenza A/H5N1 Vaccine Administered Intradermally With or Without Topical Aldara in Healthy Young Adults
Conditions: Avian Influenza; Influenza Immunisation Interventions: Other: Aqueous Cream B.P.; Drug: Imiquimod; Biological: Influenza Virus Vaccine, Monovalent A/H5N1 A/Vietnam/1203/04 Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2018 Category: Research Source Type: clinical trials
Safety and Immunogenicity of Inactivated Influenza A/H5N1 Vaccine Administered With or Without Topical Aldara
Conditions: Avian Influenza; Influenza Immunisation Interventions: Other: Aqueous Cream B.P.; Drug: Imiquimod; Biological: Influenza Virus Vaccine, Monovalent A/H5N1 A/Vietnam/1203/04 Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2018 Category: Research Source Type: clinical trials
Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Inactivated Influenza A/H5N1 Vaccine Administered Intradermally With or Without Topical Aldara in Healthy Young Adults
Conditions: Avian Influenza; Influenza Immunisation Interventions: Other: Aqueous Cream B.P.; Drug: Imiquimod; Biological: Influenza Virus Vaccine, Monovalent A/H5N1 A/Vietnam/1203/04 Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2018 Category: Research Source Type: clinical trials